CIK 0001783183 · Non-accelerated filer<br>Smaller reporting company
Phathom Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PHAT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 824151574
- Phone
- (877) 742-8466
- Business address
- 100 CAMPUS DRIVE,, SUITE 102, FLORHAM PARK, NJ, 07932
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-03 | FIELDS HEIDI Director | Grant or award | +10,500 | 30,000 | ||
| 2025-06-03 | FIELDS HEIDI Director | Grant or award · Stock Option (Right to Buy) | +17,500 | 17,500 | ||
| 2025-06-03 | Stenhouse Mark Director | Grant or award | +10,500 | 30,000 | ||
| 2025-06-03 | Stenhouse Mark Director | Grant or award · Stock Option (Right to Buy) | +17,500 | 17,500 | ||
| 2025-06-03 | Parikh Asit Director | Grant or award | +10,500 | 113,500 | ||
| 2025-06-03 | Parikh Asit Director | Grant or award · Stock Option (Right to Buy) | +17,500 | 17,500 | ||
| 2025-05-21 | Topper James N Director | Purchase | +3,780 | $3.86 | $15K | 59,403 |
| 2025-05-19 | Breedlove Robert Charles Principal Accounting Officer | Grant or award · Stock Option (Right to Buy) | +33,000 | 33,000 | ||
| 2025-05-14 | Topper James N Director | Purchase | +6,300 | $3.32 | $21K | 55,623 |
| 2025-05-13 | Topper James N Director | Purchase | +1,120 | $3.16 | $4K | 49,323 |
| 2025-05-12 | Topper James N Director | Purchase | +12,601 | $3.04 | $38K | 48,203 |
| 2025-05-09 | Topper James N Director | Purchase | +33,376 | $3.19 | $107K | 33,376 |
| 2025-05-09 | Topper James N Director | Purchase | +2,226 | $3.62 | $8K | 35,602 |
| 2025-05-07 | Parikh Asit Director | Purchase | +5,000 | $2.40 | $12K | 95,500 |
| 2025-05-06 | Parikh Asit Director | Purchase | +5,000 | $2.60 | $13K | 90,500 |
| 2025-04-16 | Schroeder Theodore R Director | Grant or award | +21,000 | 21,000 | ||
| 2025-04-16 | Schroeder Theodore R Director | Grant or award · Common Stock (Right to Buy) | +35,000 | 35,000 | ||
| 2025-04-07 | Henderson Molly CFO and CBO | Sale | −3,678 | $4.55 | $17K | 89,868 |
| 2025-04-03 | Basta Steven L President and CEO | Grant or award · Performance Shares | +360,000 | 360,000 | ||
| 2025-04-03 | Basta Steven L President and CEO | Grant or award · Stock Option (Right to Buy) | +1,085,000 | 1,085,000 |
Page 4 of 19 · 379 trades